Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

689-711 (Activation loop from InterPro)

Target domain

529-816 (Catalytic domain of Type III Phosphoinositide 4-kinase beta)

Relief mechanism

Assay

Autoinhibited structure

Activated structure

18 structures for Q9UBF8

Entry ID Method Resolution Chain Position Source
2N73 NMR - B 1-68 PDB
4D0L X-ray 294 A A/C/E 121-799 PDB
4D0M X-ray 600 A A/C/G/I/M/O/Q/S/W/Y/c/g 121-799 PDB
4WAE X-ray 332 A A 128-799 PDB
4WAG X-ray 341 A A 128-799 PDB
5C46 X-ray 265 A E 121-799 PDB
5C4G X-ray 320 A E 121-799 PDB
5EUQ X-ray 320 A PDB
5FBL X-ray 337 A A 128-799 PDB
5FBQ X-ray 379 A A 128-799 PDB
5FBR X-ray 328 A A 128-799 PDB
5FBV X-ray 329 A A 128-799 PDB
5FBW X-ray 349 A A 128-799 PDB
5LX2 X-ray 258 A B 292-297 PDB
5NAS X-ray 208 A C/D 289-297 PDB
6GL3 X-ray 277 A PDB
8Q6G X-ray 154 A A 291-816 PDB
AF-Q9UBF8-F1 Predicted AlphaFoldDB

432 variants for Q9UBF8

Variant ID(s) Position Change Description Diseaes Association Provenance
CA1089463
rs765405242
2 G>R No ClinGen
ExAC
gnomAD
CA341988189
rs1336811424
4 T>A No ClinGen
TOPMed
gnomAD
CA341988187
rs888671749
4 T>K No ClinGen
TOPMed
gnomAD
rs888671749
CA29545194
4 T>R No ClinGen
TOPMed
gnomAD
rs1232477879
CA341988184
5 V>I No ClinGen
TOPMed
gnomAD
CA1089462
rs776717338
8 P>A No ClinGen
ExAC
TOPMed
gnomAD
CA1089461
rs776717338
8 P>S No ClinGen
ExAC
TOPMed
gnomAD
CA341988156
rs1297280841
9 A>V No ClinGen
gnomAD
rs761238694
CA29545182
10 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA1089459
rs761238694
10 P>R No ClinGen
ExAC
TOPMed
gnomAD
rs764565706
CA1089460
10 P>S No ClinGen
ExAC
gnomAD
CA1089458
rs144656134
11 L>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1336585603
CA341988131
14 T>A No ClinGen
TOPMed
gnomAD
CA341988115
rs1392948705
16 E>V No ClinGen
gnomAD
CA1089456
rs759926976
17 P>T No ClinGen
ExAC
gnomAD
CA1089454
rs770637267
18 T>A No ClinGen
ExAC
TOPMed
gnomAD
rs1428114383
CA341988104
18 T>S No ClinGen
TOPMed
gnomAD
rs138899197
CA1089453
21 P>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs546072252
CA1089452
22 P>L No ClinGen
1000Genomes
ExAC
gnomAD
rs1193020301
CA341988083
22 P>S No ClinGen
gnomAD
rs769663466
CA1089451
23 G>E No ClinGen
ExAC
TOPMed
gnomAD
CA1089450
rs748098911
25 N>D No ClinGen
ExAC
gnomAD
CA341988060
rs1373443913
26 G>R No ClinGen
TOPMed
CA341988045
rs1301478367
28 S>Y No ClinGen
gnomAD
CA1089447
rs751289611
29 L>P No ClinGen
ExAC
gnomAD
rs1466593928
CA341988030
31 S>N No ClinGen
gnomAD
CA1089445
rs375599986
33 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA29545110
rs143664305
34 T>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs143664305
CA1089444
34 T>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs768094196
CA1089440
36 G>A No ClinGen
ExAC
gnomAD
rs753268967
CA1089441
36 G>R No ClinGen
ExAC
gnomAD
CA341987996
rs568964666
37 V>F No ClinGen
TOPMed
gnomAD
CA29545092
rs568964666
37 V>I No ClinGen
TOPMed
gnomAD
rs186207540
CA1089438
38 G>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs186207540
CA1089437
38 G>W No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs763814782
CA29545073
39 E>K No ClinGen
Ensembl
rs574473630
CA1089435
43 I>T No ClinGen
1000Genomes
ExAC
gnomAD
CA1089434
rs375242469
44 D>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA341987937
rs1274554646
47 V>M No ClinGen
TOPMed
rs1436680098
CA341987921
49 Q>R No ClinGen
TOPMed
rs199940125
CA29545037
50 K>E No ClinGen
Ensembl
CA341987909
rs1281859006
51 A>P No ClinGen
Ensembl
CA341987901
rs1256233305
52 C>F No ClinGen
gnomAD
rs1345196288
CA341987894
53 Q>* No ClinGen
gnomAD
CA341987892
rs1302042247
53 Q>R No ClinGen
gnomAD
CA1089432
rs781112664
54 E>A No ClinGen
ExAC
TOPMed
gnomAD
CA1089431
rs781112664
54 E>V No ClinGen
ExAC
TOPMed
gnomAD
rs141886432
CA1089428
60 K>Q No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA1089426
rs754067942
62 L>F No ClinGen
ExAC
gnomAD
CA341987824
rs1571206995
63 H>R No ClinGen
Ensembl
rs867711084
CA341987807
66 V>L No ClinGen
TOPMed
gnomAD
CA29544953
rs867711084
66 V>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs570808835
CA1089424
67 A>V No ClinGen
ExAC
gnomAD
CA341987795
rs1408231309
68 V>A No ClinGen
TOPMed
rs752756841
CA1089423
68 V>I No ClinGen
ExAC
TOPMed
gnomAD
rs967152918
CA29544945
69 S>C No ClinGen
gnomAD
rs1325585032
CA341987791
69 S>T No ClinGen
TOPMed
CA341987775
rs1331819196
71 R>S No ClinGen
TOPMed
CA341987762
rs1256582728
73 T>I No ClinGen
gnomAD
CA29544936
rs151146110
74 P>L No ClinGen
ESP
CA1089418
rs763179539
76 E>A No ClinGen
ExAC
gnomAD
rs766830443
CA1089419
76 E>K No ClinGen
ExAC
TOPMed
gnomAD
CA341987738
rs1240264890
78 V>I No ClinGen
gnomAD
CA1089417
rs772948943
79 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA1089415
rs28372941
87 I>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs140730542
CA1089414
88 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA341987669
rs140730542
88 R>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA1089413
rs199887088
88 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA341987653
rs1375095197
90 L>P No ClinGen
gnomAD
CA341987648
rs1250759118
91 D>G No ClinGen
TOPMed
rs1250759118
CA341987647
91 D>V No ClinGen
TOPMed
rs1231505306
CA341987639
92 D>E No ClinGen
TOPMed
gnomAD
rs201031914
CA29544905
92 D>V No ClinGen
1000Genomes
CA1089409
rs775310113
93 P>R No ClinGen
ExAC
gnomAD
rs1028342861
CA1089410
93 P>S No ClinGen
TOPMed
CA341987637
rs1028342861
93 P>T No ClinGen
TOPMed
rs1405881539
CA341987629
94 P>R No ClinGen
gnomAD
CA341987618
rs1156806835
96 Q>R No ClinGen
gnomAD
CA341987607
rs1474382469
97 I>M No ClinGen
TOPMed
rs771919999
CA1089408
99 E>K No ClinGen
ExAC
gnomAD
rs745606117
CA1089407
101 E>D No ClinGen
ExAC
gnomAD
rs1164989729
CA341987568
103 E>K No ClinGen
TOPMed
rs1474073616
CA341987556
104 M>I No ClinGen
TOPMed
gnomAD
CA1089406
rs778060789
104 M>L No ClinGen
ExAC
gnomAD
rs558834754
CA1089405
105 G>E No ClinGen
1000Genomes
ExAC
gnomAD
rs1256381279
CA341987552
105 G>R No ClinGen
gnomAD
CA341987545
rs1460989358
106 A>V No ClinGen
TOPMed
rs1357634358
CA341987541
107 A>P No ClinGen
TOPMed
gnomAD
CA341987542
rs1357634358
107 A>T No ClinGen
TOPMed
gnomAD
TCGA novel 108 V>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1089403
rs781415493
109 A>T No ClinGen
ExAC
gnomAD
COSM1295043
CA1089402
rs755592481
110 S>L urinary_tract [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs1355148556
CA341987517
111 G>D No ClinGen
gnomAD
CA341987490
rs1343563404
115 G>E No ClinGen
gnomAD
CA341987465
rs900967912
119 R>L No ClinGen
TOPMed
gnomAD
rs900967912
CA29544879
119 R>Q No ClinGen
TOPMed
gnomAD
rs201595401
CA341987467
119 R>W No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs750699434
CA1089398
120 R>P No ClinGen
ExAC
TOPMed
gnomAD
CA341987462
rs750699434
120 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1359198357
CA341987463
120 R>W No ClinGen
gnomAD
COSM1320002
CA29544864
rs760195563
121 Q>H ovary Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
Ensembl
NCI-TCGA
CA1089397
rs765001640
121 Q>R No ClinGen
ExAC
TOPMed
gnomAD
CA29544857
rs761452572
122 N>K No ClinGen
ExAC
gnomAD
CA341987426
rs1416887924
126 K>E No ClinGen
gnomAD
rs763569179
CA29544822
135 E>* No ClinGen
ExAC
gnomAD
rs763569179
CA1089394
135 E>K No ClinGen
ExAC
gnomAD
rs376447621
CA1089393
138 L>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1468493229
CA341987297
145 I>V No ClinGen
gnomAD
rs1275605811
CA341987281
147 Y>S No ClinGen
gnomAD
TCGA novel 149 Y>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 150 N>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA341987247
rs1270829187
152 K>R No ClinGen
TOPMed
rs774003340
CA1089389
155 G>R No ClinGen
ExAC
gnomAD
CA1089387
rs748361427
156 V>I No ClinGen
ExAC
gnomAD
CA341987200
rs1327919651
159 Y>C No ClinGen
gnomAD
TCGA novel 159 Y>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1089385
rs755140943
160 I>V No ClinGen
ExAC
gnomAD
COSM2183415
rs372795296
CA1089384
163 R>Q large_intestine [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
gnomAD
CA341987175
rs1324833163
163 R>W No ClinGen
TOPMed
rs750868780
CA1089381
168 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs765490691
CA1089380
168 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA1089379
rs756950342
169 N>S No ClinGen
ExAC
gnomAD
rs375283129
CA1089377
170 E>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA1089376
rs752090695
171 D>E No ClinGen
ExAC
TOPMed
gnomAD
CA1089374
rs767548449
172 V>M No ClinGen
ExAC
TOPMed
gnomAD
rs759385940
CA1089373
173 D>A No ClinGen
ExAC
gnomAD
CA341987093
rs774239767
175 Y>C No ClinGen
ExAC
TOPMed
gnomAD
CA1089372
rs774239767
175 Y>S No ClinGen
ExAC
TOPMed
gnomAD
CA1089369
rs776997625
180 L>F No ClinGen
ExAC
gnomAD
CA341987047
rs1350215747
182 M>T No ClinGen
gnomAD
rs747147472
CA1089368
184 I>L No ClinGen
ExAC
gnomAD
CA1089367
rs747147472
184 I>V No ClinGen
ExAC
gnomAD
rs1413526877
CA341987024
185 H>L No ClinGen
TOPMed
CA1089366
rs779995809
186 M>V No ClinGen
ExAC
gnomAD
rs1370199353
CA341986998
188 E>D No ClinGen
gnomAD
CA341986990
rs1752379
189 D>E No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA1089364
rs746335653
190 V>M No ClinGen
ExAC
gnomAD
rs779424162
CA1089363
191 G>A No ClinGen
ExAC
gnomAD
CA29544649
rs12042270
193 A>S No ClinGen
Ensembl
CA1089362
rs757645617
194 I>M No ClinGen
ExAC
gnomAD
TCGA novel 197 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1089360
rs777415980
199 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1453212083
CA341986916
201 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA1089359
rs755748841
201 R>H No ClinGen
ExAC
gnomAD
CA341986905
rs1479903252
203 R>C No ClinGen
gnomAD
rs766903450
CA1089357
COSM1333965
203 R>H Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs766903450
CA341986901
203 R>L No ClinGen
ExAC
TOPMed
gnomAD
CA29544626
rs958001241
204 Q>H No ClinGen
gnomAD
rs1278412664
CA341986869
208 F>L No ClinGen
gnomAD
TCGA novel 209 S>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs762855154
CA341986794
219 Y>C No ClinGen
ExAC
TOPMed
gnomAD
CA1089353
rs762855154
219 Y>F No ClinGen
ExAC
TOPMed
gnomAD
CA341986776
rs1297360702
222 D>G Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1415124243
CA341986770
223 M>V No ClinGen
gnomAD
CA341986736
rs1310631280
227 T>I No ClinGen
gnomAD
TCGA novel 229 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA341986709
rs1345269629
231 S>F No ClinGen
gnomAD
CA1089351
rs370367124
232 R>H No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA29544588
rs370367124
232 R>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs775690832
CA1089349
234 T>A No ClinGen
ExAC
gnomAD
CA1089348
rs772064792
235 K>R No ClinGen
ExAC
gnomAD
rs779289312
CA1089346
237 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA1089345
rs771365508
239 L>V No ClinGen
ExAC
gnomAD
CA29544520
rs868031725
242 S>L No ClinGen
Ensembl
CA341986643
rs1486267627
243 D>G No ClinGen
gnomAD
TCGA novel 243 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA341986618
rs1262544741
247 P>S No ClinGen
gnomAD
rs1217912545
CA341986611
248 A>P No ClinGen
gnomAD
rs1287590316
CA341986596
250 R>K No ClinGen
TOPMed
gnomAD
rs749710318
CA1089344
251 K>N No ClinGen
ExAC
gnomAD
rs1362106853
CA341986538
258 S>R No ClinGen
gnomAD
rs755803582
CA1089342
259 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA341986535
rs1290087530
259 P>S No ClinGen
gnomAD
CA341986536
rs1290087530
259 P>T No ClinGen
gnomAD
rs587716868
CA1089340
260 A>G No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA341986525
rs1463406163
261 P>S No ClinGen
TOPMed
gnomAD
rs1056847
CA341986514
262 D>E No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA341986498
rs1264073322
265 L>P No ClinGen
gnomAD
CA1089336
rs758408953
266 S>F No ClinGen
ExAC
TOPMed
gnomAD
rs1214245132
CA341986478
269 K>E No ClinGen
gnomAD
CA1089335
rs587726472
269 K>T No ClinGen
1000Genomes
ExAC
gnomAD
rs771211131
CA341986447
273 Q>L No ClinGen
gnomAD
rs771211131
CA29544464
273 Q>R No ClinGen
gnomAD
rs761617123
CA1089333
274 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1435098260
CA341986380
283 I>R No ClinGen
TOPMed
rs1297215520
CA341986368
285 L>F No ClinGen
gnomAD
rs1571204730
CA341986361
286 S>N No ClinGen
Ensembl
rs200424946
CA1089332
288 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs77233955
CA29544449
291 R>Q No ClinGen
TOPMed
TCGA novel 293 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA341986312
rs1418677939
294 S>G No ClinGen
TOPMed
gnomAD
CA341986311
rs1418677939
294 S>R No ClinGen
TOPMed
gnomAD
CA341986305
rs1327230346
294 S>R No ClinGen
gnomAD
rs1461961990
CA341986300
295 N>S No ClinGen
TOPMed
rs1462769194
CA341986272
299 E>G No ClinGen
TOPMed
gnomAD
CA1089329
rs587765480
300 N>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA1089328
rs200734438
COSM340138
301 E>K lung [Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
CA1089327
rs749763030
302 D>N No ClinGen
ExAC
TOPMed
gnomAD
rs1280534468
CA341985270
304 E>K No ClinGen
gnomAD
CA341985252
rs1212416768
305 L>F No ClinGen
TOPMed
gnomAD
CA341985236
rs1364707430
306 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1571188113
CA341985219
308 S>R No ClinGen
Ensembl
rs1240377428
CA341985196
COSM895772
310 E>K Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
rs766422704
CA1089310
311 S>G No ClinGen
ExAC
TOPMed
gnomAD
CA341985164
rs1306907236
312 I>T No ClinGen
TOPMed
CA1089309
rs762969703
312 I>V No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 313 D>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1409561100
CA341985149
313 D>V No ClinGen
gnomAD
rs773714401
CA1089308
314 N>D No ClinGen
ExAC
gnomAD
CA1089307
rs770279139
315 S>L No ClinGen
ExAC
gnomAD
CA29541245
rs745439382
317 S>N No ClinGen
Ensembl
COSM1722496
CA341985060
rs1355938706
319 P>S NS [Cosmic] No ClinGen
cosmic curated
gnomAD
CA1089280
rs745425649
321 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1318519438
COSM3801822
CA341984976
328 F>L Variant assessed as Somatic; 0.0 impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA341984901
rs1233982385
333 M>L No ClinGen
gnomAD
rs1166873730
CA341984868
334 A>V No ClinGen
gnomAD
rs755933059
CA1089275
336 G>S No ClinGen
ExAC
gnomAD
CA341984824
rs367965535
337 K>R No ClinGen
ESP
TOPMed
gnomAD
CA29540058
rs367965535
337 K>T No ClinGen
ESP
TOPMed
gnomAD
CA341984809
rs1188541621
338 R>Q No ClinGen
gnomAD
rs752433181
CA1089274
338 R>W No ClinGen
ExAC
gnomAD
rs1571179742
CA341984798
340 A>G No ClinGen
Ensembl
TCGA novel 340 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs780315230
CA1089273
341 T>M No ClinGen
ExAC
gnomAD
rs1571179730
CA341984796
341 T>P No ClinGen
Ensembl
CA341984778
rs1571179682
342 L>P No ClinGen
Ensembl
rs765341223
CA1089270
347 Q>H No ClinGen
ExAC
gnomAD
CA1089271
rs750543436
347 Q>R No ClinGen
ExAC
gnomAD
rs761752414
CA1089269
348 K>E No ClinGen
ExAC
gnomAD
TCGA novel 349 T>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA341984522
rs1411275969
358 L>V No ClinGen
gnomAD
TCGA novel 359 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1167441613
CA341984492
COSM528504
360 N>S lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs1248840868
CA341984414
365 A>V No ClinGen
TOPMed
TCGA novel 366 R>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1397433917
CA341984404
366 R>Q No ClinGen
TOPMed
gnomAD
rs1452015561
CA341984334
370 P>S No ClinGen
TOPMed
rs1170019492
CA341984304
372 A>T No ClinGen
TOPMed
CA341984281
rs1189975077
374 F>L No ClinGen
gnomAD
CA1089263
rs773782666
377 H>Q No ClinGen
ExAC
gnomAD
CA1089261
rs764847655
378 V>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs748704709
CA1089260
379 V>I No ClinGen
ExAC
gnomAD
rs777781696
CA1089259
381 V>A No ClinGen
ExAC
gnomAD
CA341984150
rs1571179213
382 P>L No ClinGen
Ensembl
rs1303407185
CA341984105
385 Q>* No ClinGen
gnomAD
rs200053405
CA29539916
387 V>G No ClinGen
Ensembl
TCGA novel 395 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA29538573
rs1031965556
401 V>A No ClinGen
Ensembl
CA341983582
rs1456044414
404 L>F Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs748056222
CA1089238
410 D>E No ClinGen
ExAC
TOPMed
gnomAD
rs1352819404
CA341983361
416 A>V No ClinGen
TOPMed
CA341983331
rs1486195779
417 R>W No ClinGen
gnomAD
rs777966347
CA1089231
418 I>V No ClinGen
ExAC
gnomAD
rs1267222624
CA341983265
422 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs749543339
CA1089228
423 I>K No ClinGen
ExAC
CA1089227
rs753277704
423 I>T No ClinGen
ExAC
gnomAD
CA1089226
rs200350201
424 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
rs999904324
CA29538509
424 R>W No ClinGen
Ensembl
rs1282841697
CA341983172
426 T>M No ClinGen
gnomAD
rs1323207915
CA341983132
429 V>I No ClinGen
TOPMed
gnomAD
rs761275142
CA1089219
434 E>K No ClinGen
ExAC
TOPMed
gnomAD
rs776558471
CA1089218
434 E>V No ClinGen
ExAC
rs377553648
CA1089217
435 C>* No ClinGen
ESP
ExAC
rs1307308311
CA341983038
435 C>S No ClinGen
TOPMed
gnomAD
CA29536964
rs890184716
437 I>T No ClinGen
TOPMed
CA1089216
rs746876053
439 H>R No ClinGen
ExAC
gnomAD
TCGA novel 441 Q>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1224942136
CA341981434
441 Q>H No ClinGen
TOPMed
gnomAD
rs1429255243
CA341981385
442 R>Q No ClinGen
gnomAD
CA341981351
rs1352969489
444 G>R No ClinGen
TOPMed
gnomAD
rs771222979
CA1089214
446 F>S No ClinGen
ExAC
gnomAD
CA341981153
rs1311783962
447 S>G No ClinGen
gnomAD
CA29536910
rs1051277142
449 V>M No ClinGen
Ensembl
CA341981027
rs1190472583
450 P>L No ClinGen
gnomAD
rs1463512199
CA341980988
451 N>K No ClinGen
TOPMed
gnomAD
CA1089213
rs749445506
452 Y>C No ClinGen
ExAC
TOPMed
gnomAD
rs778090293
CA1089212
455 D>N No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 459 W>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs748171554
CA1089210
461 V>A No ClinGen
ExAC
gnomAD
CA341980635
rs1307623212
462 D>G No ClinGen
gnomAD
CA29536860
rs755332671
462 D>N No ClinGen
Ensembl
CA29536851
rs934121209
466 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA1089208
rs755436866
469 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA29535132
rs367782946
473 E>K No ClinGen
ESP
TOPMed
gnomAD
CA29535126
rs778524223
474 V>G No ClinGen
Ensembl
rs1429267959
CA341979815
474 V>L No ClinGen
gnomAD
rs377615591
CA29535115
475 H>R No ClinGen
ESP
TOPMed
CA1089191
rs769257764
479 C>Y No ClinGen
ExAC
TOPMed
gnomAD
CA1089190
rs747494440
482 I>T No ClinGen
ExAC
gnomAD
CA341979615
rs1467493837
484 Q>H No ClinGen
gnomAD
COSM246576
rs1375821240
CA341979594
487 V>M prostate [Cosmic] No ClinGen
cosmic curated
gnomAD
CA1089189
rs780574306
490 I>M No ClinGen
ExAC
rs1332232140
CA341979542
490 I>V No ClinGen
TOPMed
gnomAD
CA341979525
rs1571163850
491 T>P No ClinGen
Ensembl
rs758697095
CA1089188
499 V>A No ClinGen
ExAC
gnomAD
CA341979380
rs1197933832
499 V>L No ClinGen
TOPMed
gnomAD
rs1197933832
CA341979383
499 V>M No ClinGen
TOPMed
gnomAD
rs1253608770
CA341979339
501 I>T No ClinGen
gnomAD
rs1482470144
CA341979330
502 A>P No ClinGen
gnomAD
CA1089186
rs778599326
504 G>E No ClinGen
ExAC
gnomAD
rs753382269
CA1089184
505 D>N No ClinGen
ExAC
gnomAD
rs587638204
CA1089183
507 R>H No ClinGen
1000Genomes
ExAC
gnomAD
CA341979113
rs1475598433
508 R>Q No ClinGen
TOPMed
gnomAD
rs767412026
CA1089160
508 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA341979109
rs1435684202
509 R>C No ClinGen
gnomAD
CA341979108
rs1390693887
509 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs1318315687
CA341979077
511 S>L No ClinGen
gnomAD
rs1481497274
CA341979047
513 Q>R No ClinGen
TOPMed
rs766301277
COSM1663487
CA1089157
514 L>Q kidney [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs1557792249
CA341978996
516 H>Y No ClinGen
Ensembl
CA29533839
rs376699620
518 P>L No ClinGen
ESP
TOPMed
gnomAD
CA341978914
rs1367360537
519 T>R No ClinGen
gnomAD
CA1089155
rs776726452
522 K>R No ClinGen
ExAC
TOPMed
gnomAD
rs764322175
CA1089154
523 R>Q No ClinGen
ExAC
gnomAD
rs1208511619
CA341978702
526 E>D No ClinGen
gnomAD
rs775637962
CA1089152
534 K>R No ClinGen
ExAC
TOPMed
gnomAD
rs930682258
CA29533801
537 W>* No ClinGen
Ensembl
CA29533796
rs753489098
541 V>A No ClinGen
TOPMed
gnomAD
rs1355780351
CA341978285
542 R>Q No ClinGen
gnomAD
rs1305583915
CA341978295
542 R>W No ClinGen
TOPMed
rs1207384521
CA341977001
543 R>Q No ClinGen
gnomAD
TCGA novel 546 E>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1227549677
CA341976812
551 G>S No ClinGen
TOPMed
gnomAD
rs267598012
CA29533575
555 N>D No ClinGen
gnomAD
rs145183469
CA1089137
555 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA1089136
rs145183469
555 N>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs372597812
CA1089134
557 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs151090491
CA1089135
557 R>W No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs745689241
CA29533546
558 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA341976573
rs1246623234
560 S>P No ClinGen
TOPMed
CA341976248
rs1477864133
570 R>Q No ClinGen
gnomAD
rs1218091769
CA341976264
570 R>W No ClinGen
TOPMed
rs1485635449
CA341976135
575 A>G No ClinGen
TOPMed
rs1482144787
CA341976065
578 V>M No ClinGen
gnomAD
CA341976025
rs1273973139
580 K>R No ClinGen
gnomAD
rs587741228
CA1089128
582 L>M No ClinGen
1000Genomes
ExAC
gnomAD
rs760216451
CA29533507
583 Q>R No ClinGen
Ensembl
CA341975522
rs1228462683
587 E>Q No ClinGen
gnomAD
CA1089112
rs766938242
588 Q>K No ClinGen
ExAC
gnomAD
TCGA novel 589 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs773543566
CA1089110
COSM895769
590 R>Q Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs762018174
CA1089108
591 V>M No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 592 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1455923457
CA341975426
595 I>M No ClinGen
gnomAD
CA341975417
rs1411519264
597 P>S No ClinGen
TOPMed
gnomAD
TCGA novel 599 K>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1089104
rs148958963
601 L>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA29531193
rs950155929
604 S>L Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA29531149
rs368818592
609 M>V No ClinGen
ESP
rs376160455
CA29531141
610 I>T No ClinGen
ESP
rs1210357334
CA341975309
613 V>M No ClinGen
gnomAD
rs991456438
CA29531138
614 V>A No ClinGen
TOPMed
gnomAD
CA341975302
rs1463373604
614 V>I No ClinGen
gnomAD
rs757077995
CA1089100
616 A>G No ClinGen
ExAC
gnomAD
rs1221817303
CA341975290
616 A>T No ClinGen
gnomAD
rs757077995
CA341975286
616 A>V No ClinGen
ExAC
gnomAD
rs753517474
CA1089099
619 I>V No ClinGen
ExAC
TCGA novel 624 K>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA29531095
rs749628103
629 S>A No ClinGen
ExAC
gnomAD
CA1089097
rs749628103
629 S>T No ClinGen
ExAC
gnomAD
TCGA novel 631 L>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs766469914
CA1089095
632 D>N No ClinGen
ExAC
gnomAD
TCGA novel 636 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1310566755
CA341975151
636 Q>R No ClinGen
TOPMed
CA341975121
rs1222893053
640 S>T No ClinGen
Ensembl
CA1089090
rs777134370
645 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs1190417371
COSM895766
CA341975046
651 R>H Variant assessed as Somatic; 0.0 impact. central_nervous_system endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA29531041
rs926221213
655 Q>E No ClinGen
TOPMed
rs1191516445
CA341974846
663 V>L No ClinGen
gnomAD
rs1212802910
CA341972338
679 L>V No ClinGen
TOPMed
TCGA novel 679 L>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1089073
rs757677169
682 E>D No ClinGen
ExAC
gnomAD
rs765842263
CA1089074
682 E>G No ClinGen
ExAC
gnomAD
rs1244333999
CA341972133
688 I>V No ClinGen
TOPMed
TCGA novel 689 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 696 S>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 699 R>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1089070
rs587658940
699 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
rs775283031
CA1089069
701 L>M No ClinGen
ExAC
gnomAD
rs1276735332
CA341971692
705 T>M No ClinGen
gnomAD
CA341971655
rs1282935713
707 A>P No ClinGen
gnomAD
rs144699802
CA1089067
712 T>A No ClinGen
ESP
ExAC
rs1303914392
CA341971523
712 T>I No ClinGen
gnomAD
CA341971528
rs1303914392
712 T>K No ClinGen
gnomAD
rs1470997870
CA341971507
713 E>A No ClinGen
TOPMed
CA29528070
rs906578656
716 D>H No ClinGen
gnomAD
CA29527840
rs147243395
717 V>M No ClinGen
ESP
TOPMed
gnomAD
CA341971272
rs1286062069
719 G>D No ClinGen
gnomAD
CA1089034
rs202221345
720 G>D No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs963641492
CA29527833
720 G>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA341971227
rs1314285138
723 G>V No ClinGen
TOPMed
gnomAD
rs926614750
CA29527828
725 M>L No ClinGen
Ensembl
rs753147951
CA1089031
727 N>S No ClinGen
ExAC
gnomAD
rs756687625
CA1089032
727 N>Y No ClinGen
ExAC
gnomAD
CA341971057
rs1224312691
735 Q>E No ClinGen
TOPMed
rs751176176
CA1089028
735 Q>R No ClinGen
ExAC
gnomAD
rs587759767
CA1089026
740 A>T No ClinGen
1000Genomes
ExAC
gnomAD
rs373500632
CA29527786
744 M>V Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ESP
NCI-TCGA
TOPMed
CA341970918
rs1451775938
746 K>E No ClinGen
gnomAD
CA1089025
rs765196916
750 I>M No ClinGen
ExAC
TOPMed
gnomAD
CA1089023
rs776579808
751 V>L No ClinGen
ExAC
gnomAD
CA1089022
rs776579808
751 V>M No ClinGen
ExAC
gnomAD
CA341970817
rs1452434094
753 I>T No ClinGen
gnomAD
rs1025061864
CA29527775
757 G>S No ClinGen
Ensembl
TCGA novel 758 S>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1088971
rs772427493
761 P>S No ClinGen
ExAC
gnomAD
rs1557781017
CA341968872
764 H>R No ClinGen
Ensembl
rs1571119513
CA341968838
767 S>G No ClinGen
Ensembl
CA341968820
rs1571119502
768 T>S No ClinGen
Ensembl
TCGA novel 770 R>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 770 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA341968755
rs1343452484
773 K>R No ClinGen
TOPMed
gnomAD
TCGA novel 773 K>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 776 F>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA341968709
rs1292275990
777 H>Y No ClinGen
TOPMed
rs773394398
CA29527062
778 M>V No ClinGen
TOPMed
CA1088967
rs748792388
779 S>G No ClinGen
ExAC
gnomAD
CA29527060
rs1025558522
780 M>K No ClinGen
TOPMed
gnomAD
rs777318720
CA1088966
781 T>I No ClinGen
ExAC
gnomAD
rs755533251
CA1088965
783 E>Q No ClinGen
ExAC
gnomAD
TCGA novel 783 E>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs755533251
CA341968613
783 E>K No ClinGen
ExAC
gnomAD
CA341968574
rs1557780871
784 Q>H No ClinGen
Ensembl
TCGA novel 785 L>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1571119253
CA341968487
789 V>G No ClinGen
Ensembl
rs1571119227
CA341968396
793 V>G No ClinGen
Ensembl
rs1447598009
CA341968292
COSM895764
798 R>W Variant assessed as Somatic; impact. central_nervous_system endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
rs1571119180
CA341968275
799 S>A No ClinGen
Ensembl
CA341968250
rs1172273752
800 I>L No ClinGen
gnomAD
CA341968225
rs1571119148
801 T>P No ClinGen
Ensembl
CA341968097
rs1191391542
807 G>S No ClinGen
gnomAD
CA29527006
rs965459912
814 G>S No ClinGen
TOPMed

No associated diseases with Q9UBF8

4 regional properties for Q9UBF8

Type Name Position InterPro Accession
domain Phosphatidylinositol 3-/4-kinase, catalytic domain 535 - 814 IPR000403
domain Phosphoinositide 3-kinase, accessory (PIK) domain 29 - 242 IPR001263
conserved_site Phosphatidylinositol 3/4-kinase, conserved site 563 - 577 IPR018936-1
conserved_site Phosphatidylinositol 3/4-kinase, conserved site 656 - 676 IPR018936-2

Functions

Description
EC Number 2.7.1.67 Phosphotransferases with an alcohol group as acceptor
Subcellular Localization
  • Endomembrane system
  • Mitochondrion outer membrane; Peripheral membrane protein
  • Rough endoplasmic reticulum membrane; Peripheral membrane protein
  • Golgi apparatus
  • Golgi apparatus membrane
  • Cytoplasm, perinuclear region
  • Found in the outer membrane of mitochondria and membranes of the rough endoplasmic reticulum
  • Recruited to the Golgi complex by the small GTPase ARF to stimulate the synthesis of phosphatidylinositol 4,5-bisphosphate (PIP2) on the Golgi complex
  • Recruited to the Golgi apparatus membrane by ACBD3 (PubMed:24672044, PubMed:27009356, PubMed:28289207)
  • GGA2 is also involved in the recruitment (PubMed:28289207)
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

9 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
endosome A vacuole to which materials ingested by endocytosis are delivered.
Golgi apparatus A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways.
Golgi membrane The lipid bilayer surrounding any of the compartments of the Golgi apparatus.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
mitochondrial outer membrane The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope.
perinuclear region of cytoplasm Cytoplasm situated near, or occurring around, the nucleus.
rough endoplasmic reticulum membrane The lipid bilayer surrounding the rough endoplasmic reticulum.

4 GO annotations of molecular function

Name Definition
1-phosphatidylinositol 4-kinase activity Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol + ATP = 1-phosphatidyl-1D-myo-inositol 4-phosphate + ADP + 2 H(+).
14-3-3 protein binding Binding to a 14-3-3 protein. A 14-3-3 protein is any of a large family of approximately 30kDa acidic proteins which exist primarily as homo- and heterodimers within all eukaryotic cells, and have been implicated in the modulation of distinct biological processes by binding to specific phosphorylated sites on diverse target proteins, thereby forcing conformational changes or influencing interactions between their targets and other molecules. Each 14-3-3 protein sequence can be roughly divided into three sections: a divergent amino terminus, the conserved core region and a divergent carboxy-terminus. The conserved middle core region of the 14-3-3s encodes an amphipathic groove that forms the main functional domain, a cradle for interacting with client proteins.
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
phosphatidylinositol kinase activity Catalysis of the reaction: ATP + a phosphatidylinositol = ADP + a phosphatidylinositol phosphate.

7 GO annotations of biological process

Name Definition
lysosome organization A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a lysosome. A lysosome is a cytoplasmic, membrane-bounded organelle that is found in most animal cells and that contains a variety of hydrolases.
phosphatidylinositol biosynthetic process The chemical reactions and pathways resulting in the formation of phosphatidylinositol, any glycophospholipid in which the sn-glycerol 3-phosphate residue is esterified to the 1-hydroxyl group of 1D-myo-inositol.
phosphatidylinositol phosphate biosynthetic process The chemical reactions and pathways resulting in the formation of phosphatidylinositol phosphate.
phosphatidylinositol-mediated signaling The series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives.
phosphorylation The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
receptor-mediated endocytosis An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
signal transduction The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.

12 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P39104 PIK1 Phosphatidylinositol 4-kinase PIK1 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
O02810 PI4KB Phosphatidylinositol 4-kinase beta Bos taurus (Bovine) PR
P42356 PI4KA Phosphatidylinositol 4-kinase alpha Homo sapiens (Human) PR
O00443 PIK3C2A Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha Homo sapiens (Human) PR
P48736 PIK3CG Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (Human) PR
P42336 PIK3CA Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens (Human) PR
P42338 PIK3CB Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Homo sapiens (Human) PR
O00329 PIK3CD Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Homo sapiens (Human) PR
Q8BKC8 Pi4kb Phosphatidylinositol 4-kinase beta Mus musculus (Mouse) PR
O08561 Pi4kb Phosphatidylinositol 4-kinase beta Rattus norvegicus (Rat) PR
A4IID4 pi4kb Phosphatidylinositol 4-kinase beta Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
Q49GP3 pi4kb Phosphatidylinositol 4-kinase beta Danio rerio (Zebrafish) (Brachydanio rerio) PR
10 20 30 40 50 60
MGDTVVEPAP LKPTSEPTSG PPGNNGGSLL SVITEGVGEL SVIDPEVAQK ACQEVLEKVK
70 80 90 100 110 120
LLHGGVAVSS RGTPLELVNG DGVDSEIRCL DDPPAQIREE EDEMGAAVAS GTAKGARRRR
130 140 150 160 170 180
QNNSAKQSWL LRLFESKLFD ISMAISYLYN SKEPGVQAYI GNRLFCFRNE DVDFYLPQLL
190 200 210 220 230 240
NMYIHMDEDV GDAIKPYIVH RCRQSINFSL QCALLLGAYS SDMHISTQRH SRGTKLRKLI
250 260 270 280 290 300
LSDELKPAHR KRELPSLSPA PDTGLSPSKR THQRSKSDAT ASISLSSNLK RTASNPKVEN
310 320 330 340 350 360
EDEELSSSTE SIDNSFSSPV RLAPEREFIK SLMAIGKRLA TLPTKEQKTQ RLISELSLLN
370 380 390 400 410 420
HKLPARVWLP TAGFDHHVVR VPHTQAVVLN SKDKAPYLIY VEVLECENFD TTSVPARIPE
430 440 450 460 470 480
NRIRSTRSVE NLPECGITHE QRAGSFSTVP NYDNDDEAWS VDDIGELQVE LPEVHTNSCD
490 500 510 520 530 540
NISQFSVDSI TSQESKEPVF IAAGDIRRRL SEQLAHTPTA FKRDPEDPSA VALKEPWQEK
550 560 570 580 590 600
VRRIREGSPY GHLPNWRLLS VIVKCGDDLR QELLAFQVLK QLQSIWEQER VPLWIKPYKI
610 620 630 640 650 660
LVISADSGMI EPVVNAVSIH QVKKQSQLSL LDYFLQEHGS YTTEAFLSAQ RNFVQSCAGY
670 680 690 700 710 720
CLVCYLLQVK DRHNGNILLD AEGHIIHIDF GFILSSSPRN LGFETSAFKL TTEFVDVMGG
730 740 750 760 770 780
LDGDMFNYYK MLMLQGLIAA RKHMDKVVQI VEIMQQGSQL PCFHGSSTIR NLKERFHMSM
790 800 810
TEEQLQLLVE QMVDGSMRSI TTKLYDGFQY LTNGIM